Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00002419
Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002419
Protocol Section: NCT00002419
Start Identification Module Data
Expand Identification Module Data
Brief Title: Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
Official Title: A Phase II 24-Week Open-Label Study Designed to Evaluate the Safety Tolerability and Efficacy of Novel Quadruple-Combination Therapy With Preveon Adefovir Dipivoxil Bis-POM PMEA Abacavir 1592U89 Sustiva Efavirenz DMP-266 and Amprenavir 141W94 for the Treatment of HIV-1 Infection in Patients Who Have Failed Previous Protease Inhibitor Treatment
Acronym: None
Organization: NIH AIDS Clinical Trials Information Service
Organization Class: INDUSTRY
Organization Study ID: 299A
Secondary IDs
Secondary ID Type Domain Link
ICC 605 None None None
Start Status Module Data
Status Verified Date: 1999-11
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Gilead Sciences
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Gilead Sciences
Start Oversight Module Data No Oversight Module Defined
Description Module: 4819
Study Last Update Post Date Type(Status Module):
Attachment: Upload